Pfizer says a smaller dose of their COVID-19 vaccine is safe to use on children ages 5-11 years old, but here’s why it could take weeks for approval. RELATED:
Pfizer-BioNTech's COVID-19 vaccine is safe and effective for children ages 5 to 11 at one-third the dose used in adolescents and adults, according to a new study from the companies.
Many parents have been eagerly awaiting a vaccine for children, who have returned to school amidst a national wave of COVID-19 cases. Cases of COVID-19 in children have jumped about 240% since July.
Children are less likely to become severely ill from COVID-19 than adults, but they can catch and pass on the virus and occasionally suffer serious disease and long-term consequences.
» Subscribe to USA TODAY:
» Watch more on this and other topics from USA TODAY:
» USA TODAY delivers current local and national news, sports, entertainment, finance, technology, and more through award-winning journalism, photos, videos and VR.